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Résumé 
Ce travail porte sur l'étude rétrospective d'une série de jeunes patients opérés de 
glaucomes pédiatriques. Le but est d'évaluer le résultat au long cours d'une 
intervention chirurgicale combinant une sclérectomie profonde et une 
trabéculectomie (sclérectomie profonde pénétrante). 
Durant la période de mars 1997 à octobre 2006, 28 patients on été suivis pour 
évaluer le résultat de cette chirurgie effectuées sur 35 yeux. Un examen 
ophtalmologique complet a été pratiqué avant la chirurgie, 1 et 7 jours, puis 1, 2, 3, 
4, 6, 9, 12 mois, enfin tous les 6 mois après l'opération. Les critères d'évaluation du 
résultat postopératoire sont: les changements de pression intraoculaire, le 
traitement antiglaucomateux adjuvant, le taux de complication, le nombre de reprises 
chirurgicales, l'erreur de réfraction, la meilleure acuité visuelle corrigée, l'état et le 
diamètre de la cornée. 
L'âge moyen est de 3.6 ± 4.5 ans et le suivi moyen de 3.6 ± 2.9 ans. La pression 
intraoculaire préopératoire de 31.9 ± 11.5 mmHg baisse de 58.3% (p<0.005) à la fin 
du suivi. Sur les 14 patients dont l'acuité visuelle a pu être mesurée, 8 (57.1 %) ont 
une acuité égale ou supérieure à 5/109 , 3 (21.4%) une acuité de 2/109 après 
intervention. Le taux de succès cumulatif complet à 9 ans est de 52.3%, le succès 
relatif 70.6%. Les complications menaçant la vision (8.6%) ont été plus fréquentes 
dans les cas de glaucome réfractaire. 
Pour conclure la sclérectomie profonde combinée à une trabéculectomie est une 
technique chirurgicale développée afin de contrôler la pression intraoculaire dans les 
cas de glaucomes congénitaux, juvéniles et secondaires. Les résultats 
intermédiaires sont encourageants et prometteurs. Les cas préalablement opérés 
avant cette nouvelle technique ont cependant un pronostic moins favorable. Le 
nombre de complications menaçant la vision est essentiellement lié à la sévérité du 
glaucome et au nombre d'interventions préalables. 
2 
1 ~ 
Deep Sclerectomy combined with Tra.beculectomy in Pedia.tric 
Gla.ucoma. 
Michael Feusier, MD*; Sylvain Roy, MD, PhD* ; André Mermoud, MD 
Glaucoma Unit, Jules Gonin Eye Hospital, University of Lausanne 
Av de France 15, CH-1004 Lausanne 
*: These authors have equally contributed to this work. 
None of the authors have any financial or proprietary interests in any product, 
method or material presented in this paper 
This paper has been presented as a poster at the 2007 World Glaucoma Congress 
in Singapore and at the 2008 ARVO Convention in Fort Lauderdale 
This manuscript contains 1 video clip 
This work was not supported by any funding 
Address for correspondence: 
Dr. Sylvain Roy 
Glaucoma Unit 
Jules Gonin Eye Hospital 
Av. De France 15 
CH-1004 Lausanne 
Phone :+4121 626 82 24 
Fax :+41 21 626 82 46 
Email: sylvain.roy@epfl.ch 
3 
Abstract 
Purpose: To evaluate the outcomes of combined deep sclerectomy and 
trabeculectomy (penetrating deep sclerectomy) in pediatric glaucoma. 
Design: Retrospective, non-consecutive, non-comparative, interventional case 
se ries. 
Participants: Children suffering from pediatric glaucoma who underwent 
surgery between March 1997 and October 2006 were included in this study. 
Methods: 
A primary combined deep sclerectomy and trabeculectomy was performed in 35 
eyes of 28 patients. Complete examinations were performed before surgery, 
postoperatively at 1 and 7 days, at 1, 2, 3, 4, 6, 9, 12 months and then every 6 
months after surgery. 
Main Outcome Measures: Surgical outcome was assessed in terms of 
intraocular pressure (IOP) change, additional glaucoma medication, 
complication rate, need for surgical revision, as well as refractive errors, best 
corrected visual acuity (BCVA), and corneal clarity and dîameters. 
Results: 
The mean age before surgery was 3.6 ± 4.5 years, and the mean follow-up was 3.5 ± 
2.9 years. The mean preoperative IOP was 31.9 ± 11.5 mmHg. At the end of follow-
up, the mean IOP decreased by 58.3% (p<0.005), and from 14 patients with 
available BCVA 8 patients (57.1 %) achieved 0.5 (20/40) or better, 3 (21.4%) 0.2 
(20/1 OO), and 2 (14.3%) 0.1 (20/200) in their better eye. The mean refractive error 
(spherical equivalent) at final follow-up visits was +0.83 ± 5.4. Six patients (43%) 
were affected by myopia. The complete and qualified success rates, based on a 
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cumulative survival curve, after 9 years were 52.3% and 70.6%, respectively 
(p<0.05). Sight threatening complications were more common (8.6%) in refractory 
glaucomas. 
Conclusions: 
Combined deep sclerectomy and trabeculectomy is a surgical technique developed 
to contrai IOP in congenital, secondary and juvenile glaucomas. The intermediate 
results are satisfactory and promising. Previous classic glaucoma surgeries 
performed before this new technique had less favourable results. The number of 
sight threatening complications is related to the severity of glaucoma and number of 
previous surgeries. 
Key words: 
Infant, Newborn; Filtering surgery; Glaucoma; Glaucoma/surgery; Trabeculectomy 
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Introduction 
Congenital and pediatric glaucomas are difficult to handle for 
ophthalmologists. Only early recognition and treatment can help physicians in 
preserving sight for these young patients. 1· 2 
As early as 1869 congenital glaucoma was identified as a likely cause for the 
specific features accompanying the classic ocular triad: epiphora, photophobia, and 
blepharospasm. The exact definition of congenital glaucoma may vary among 
several authors reporting on this entity. 1' 2' 3 Congenital glaucoma most generally 
defines a glaucoma disease occurring as early as at birth and extending upon the 3rd 
year of lite. Following that period in lite glaucoma is then defined as a juvenile 
glaucoma which may extend up to 15-year old children. The Schaffer-Weiss 
classification encompasses three forms of developmental glaucoma: the primary 
infantile glaucoma; the glaucoma associated with developmental disorders; and the 
acquired glaucoma. 
Many efforts have been developed for detecting congenital glaucoma which 
require careful and comprehensive examinations of the child's eye under general 
anesthesia. 4' 5 This procedure allows a correct examination of the anatomy of the 
anterior segment including the cornea, the iris and the iridocorneal angle, the lens 
and the fundus, and precise measurement of the intraocular pressure (IOP). There is 
a general consensus that congenital glaucoma is best treated by surgery and that 
medical treatment is not a long term solution for controlling IOP over time. 3• 6• 7 
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Several surgical procedures have been advocated to restore the aqueous 
humor pathway and to lower the elevated IOP. 1• 2• 3 Goniotomy, first described by 
Barkan in the 1930's, consists in severing the trabeculum and putative Barkan's 
membrane which is thought to impede easy aqueous humor egress. After this 
procedure the aqueous humor is drained through the trabeculum aperture. 1' 8 The 
trabeculotomy was proposed later as a means to open the trabeculum from the 
external side of the anterior segment to facilitate the outflow of aqueous humor. 9' 10 
A classic trabeculectomy was also considered a surgical option for removing the 
obstacle to the aqueous humor pathway in congenital glaucoma. 11 -14 
The deep sclerectomy, described in the 1990's, was initially indicated for the 
surgical treatment of primary open angle glaucoma and other forms of secondary 
open angle glaucomas in adult patients. 15 Deep sclerectomy was proposed to 
decrease the number of postoperative complications as well as to reduce the size of 
the subconjunctival filtering bleb as compared to the trabeculectomy. The opening of 
the trabeculo-Descemet's membrane and the basal iridectomy have been proposed 
further in cases where Schlemm's canal appeared to be absent or when aqueous 
humour outflow was deemed insufficient, to suppress the need for a secondary 
goniopuncture. 16' 17 
ln this paper we present the results of primary combined deep sclerectomy 
and trabeculectomy for the treatment for congenital and pediatric glaucomas in 
patients with up to a 9-year follow up period. 
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Patients and Methods 
Patients 
This retrospective, non-consecutive, non-comparative case series took place 
at the Glaucoma Unit of the Ophthalmology Department, University of Lausanne, 
Switzerland. Between March 1997 and October 2006, 35 eyes of 28 patients with 
pediatric glaucoma underwent primary combined deep sclerectomy and 
trabeculectomy. Children operated on were suffering from primary congenital 
glaucoma, developmental disorders, or secondary glaucoma associated with ocular 
diseases. The patients, non consecutive cases, were enrolled in this study after 
formai approval by the Ethical Committee of the University of Lausanne. Preference 
for this technique compared to other filtering surgery was given based on the 
surgeon (AM) clinical experience and actual clinical status. Each patient's legal 
representative received a comprehensive explanation about the surgery, its 
implications and signed a written informed consent prior to the surgery. 
Pediatric glaucoma was defined by an elevated IOP, an enlarged corneal 
diameter and/or cornea cloudiness, Descemet tears or Haab's striae, and/or 
abnormal anterior chamber findings under gonioscopy, as assessed by an 
experienced glaucoma specialist (AM). Sorne patients were temporarily under 
medical therapy (one or more antiglaucoma medications) and/or had previous failed 
filtering surgeries. ln eyes with a previous failed filtering surgery, the quadrant used 
to perform the combined surgery was different from the initial surgery. The motivation 
for this was to minimize interferences with possible conjunctival scarring or 
remodeling reaction from the former surgery. 
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The clinical outcome assessment included refractive errors, best corrected 
visual acuity (BCVA), corneal status and diameters, axial length, gonioscopy, 
intraocular pressure (IOP), rates of surgical complications and success. 
Data Recorded Preoperatively 
Each patient underwent a comprehensive ophthalmic examination that 
included measurement of the distance BCVA, when practical, using Snellen charts at 
6 meters, anterior segment slit lamp biomicroscopy including corneal parameters 
(diameter, pachymetry, clarity, presence of Haab's strias), fundus examination with 
optic dise evaluation, axial length, automated refraction, two IOP measurement 
readings with the Goldmann applanation tonometer or the Perkins tonometer for 
tonometry under general anesthesia. 
Surgical procedures 
Ali operations were performed by one experienced ophthalmic surgeon (AM) 
under general anesthesia, as shown in online video (video clip 1 available at 
http://aaojournal.org). The technique consisted in a limbus-based conjunctiva 
opening, followed by the creation of a superficial scierai flap measuring 5 by 5 mm, 
one third full sciera thickness. ln case of previous external failed filtering surgery (i.e. 
trabeculectomy) the conjunctiva opening and the scierai flap were performed in a site 
free of tissue scarring. A sponge soaked with Mitomycin C (0.2 mg/ml) was applied 
for about 1 minute in eyes with previous filtering surgery to prevent recurrence of 
failure and in eyes with secondary glaucoma due to uveitis or Sturge-Weber to 
prevent scarring of the filtering bleb. A deep scierai flap measuring 4 by 4 mm, 
leaving only a very thin layer of sciera with a barely visible choroidal underneath was 
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then dissected down to the Schlemm's canal (in primary congenital and 
developmental glaucomas Schlemm's canal was often difficult to clearly identify) and 
gently eut at the level of the trabeculo-descemet's membrane. This dissection 
provided an intrascleral space to draw off aqueous humor to the drainage channels. 
At that point the classical deep sclerectomy procedure was modified and a small 
portion of the trabeculum (about 3 to 4 mm) was removed to perform the 
trabeculectomy. This modification has been proposed to avoid the need for further 
laser goniopuncture as it is the case for non-penetrating deep sclerectomy. A 
cylindrical collagen implant (Aquaflow®) was secured onto the deep scierai bed to 
act as a space maintainer for the scierai space. The superficial scierai flap was 
sutured with several Nylon 10-0 single knots. The degree of tightness on the scierai 
flap was assessed by a balanced sait solution injected in the anterior chamber 
through a side port. The filtration was titrated to allow a gentle and continuous flow 
egress. Viscoelastic was injected into the anterior chamber through a paracenthesis. 
After an efficient filtration was achieved, the conjunctiva was closed with a 8-0 
Vicryl® running suture. Postoperative treatment consisted in topical application of 
tobramycin and dexamethasone 5x/day for one month, followed by ketorolac TID for 
2 months. 
Criteria for success 
Successful outcomes were divided into two groups, criterion A and criterion B. 
ln order to meet criterion A, an IOP without medication greater than 6 mmHg but < 
18 mmHg was required. ln order to meet criterion B, an IOP without medication less 
than or equal to 15 mmHg was required. Qualified success used the same criteria 
with or without medication. Failure occurred when IOP was higher than 18 mmHg 
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despite maximally tolerated medication, and/or further glaucoma surgery was 
required, or the sight was lost. Postoperative bleb management and fibrosis 
modulation using the needling technique, with or without Mitomycin C (MMC) 
injection, were nota criterion for failure. IOP data were collected at the last follow-up 
to determine success. 
Postoperative follow-up 
lntraocular pressure, mean number of medications, best corrected visual 
acuity (when possible), refractive errors, and complications were recorded 
preoperatively on two separate days, at 1 and 7 days, at 1, 2, 3, 4, 6, 9, 12 months 
and then every 6 months after surgery or more often when required by the clinical 
situation. The last follow-up data consisted of the mean of two separate day 
measurements. 
Any complication was recorded and was defined as either a major or a minor 
complication based on the clinical significance and importance overtime. Evaluation 
of the complications was based on the surgeon's clinical experience. The minor 
complications were hyphema, shallow anterior chamber and choroidal detachment. 
Hyphema was present when blood collection was seen in the anterior chamber. 
Anterior chamber depth was clinically assessed under slit lamp examination and was 
considered shallow when iridocorneal touch in the periphery was noticed. Choroidal 
detachment was observed under indirect ophthalmoscopy. Ali these complications 
were considered minor as they either resolved spontaneously or required minimal 
surgical revision. The major complications were endophthalmitis, total choroidal 
detachment or phthisis bulbi. 
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When the filtering bleb, at any postoperative visit, was encysted or showed 
signs of fibrosis leading to an increase in IOP > 20 mmHg, subconjunctival injections 
of MMC were administered. The subconjunctival injections consisted of 0.05-0.1 ml 
of a 0.02 % MMC solution injected beneath the filtering bleb under topical 
anaesthesia. 
Materials 
The collagen implant is a cylindrical device (length: 4 mm; diameter: 1 mm) 
made from lyophilized porcine scierai collagen (Aquaflow ® Staar Surgical AG, 
Nidau, Switzerland). 
Statistical analysis 
Data are expressed as the mean ± standard deviation SD, (range, min-max). 
Results were analyzed using Student t-test for parametric data (IOP), Wilcoxon 
signed-rank test for non-parametric data (BCVA, number of medication) and Kaplan-
Meier survival curves for the success rate calculation. Results were considered 
significant when p<0.05. With an n-value of 35 we have at least 90% power to detect 
differences in IOP before and after surgery of at least 3 mmHg with a SD of 3 mmHg 
at a 2-sided alpha level of 0.05. 
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Results 
Patient Demographics 
A primary combined deep sclerectomy and trabeculectomy was performed in 
35 eyes of 28 patients. The mean age of the patients before surgery was 3.6 ± 4.5 
years (3 days-13 years). Seventeen patients (60.7%) had primary congenital 
glaucoma (23 eyes), whereas 6 patients (21.4%) suffered from developmental 
disorders. Four (14.2%) of these patients had a Sturge-Weber syndrome (4 eyes), 1 
(3.6%) a neurofibromatosis (1 eye), and 1 (3.6%) a Cogan syndrome (1 eye). Five 
patients (17.9%) had secondary glaucoma. These resulted from uveitis and aphakia 
in 2 eyes of the same patient (7.1 %), aphakia and vitrectomy in 2 eyes of two 
patients (7.1 %), uveitis in 1 eye of one patient (3.5%) and late onset primary juvenile 
glaucoma after trauma at the age of 13 years in 1 eye of one patient (3.5%). The 4 
cases of aphakia resulted from congenital cataract removal (phacoemulsification) 
prier to entering this study. Ali data are set on table 1. The mean follow-up was 3.5 ± 
2.9 years (3 months-9.1 years). For one patient the surgery was performed 3 days 
postnatal, but he died 2.5 years later for medical reasons not related to the eye 
disease. Five patients (6 eyes) had previous glaucoma surgeries at a mean time 2.5 
± 1.4 years before the combined surgery presented here; trabeculectomy was 
performed on 5 eyes of four patients, and goniotomy on 1 eye of one patient. 
lntraocular pressure 
The mean preoperative IOP was 31.9 ± 11.5 mmHg (16-53 mmHg). Fifteen 
eyes (42.8%) were under antiglaucoma medication prier to undergoing filtering 
surgery. The mean preoperative number of medications per patient was 1.1 ± 1.7 (0-
5). These medications were prescribed to lower the IOP after the congenital 
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glaucoma had been confirmed based on the clinical examination but prior to 
glaucoma surgery. At the final follow-up visits, the mean IOP was 13.3 ± 5.6 mmHg 
(2-31 mmHg), thus representing a decrease of 18.6 mmHg (-58.3%) between 
preoperative and postoperative data, (p<0.005), (figures 1 and 2) (table 4). The 
mean number of medications per patient (table 2) went down to 0.4 ±0.7 (0-3) at the 
completion of the follow-up, (p<0.005). Nine eyes (25.7%) required 1 to 3 
antiglaucoma treatments to contrai IOP (figure 3). 
Cornea parameters 
Mean preoperative horizontal corneal diameters were 13.1 ± 1.4 mm (10-17 
mm). Twelve eyes (34.3%) had corneal edema, and 11 eyes (31.4%) showed Haab 
striation at the initial clinical examination. One year after surgery, mean horizontal 
corneal diameters were 13.2 ± 1.3 mm (12-16 mm). There was no significant 
difference in corneal diameters before and after surgery. Only one eye (2.8%) 
presented persistent corneal clouding, and 11 eyes (31.4%) were still showing 
Haab's strias 12 months after surgery. The improvement in corneal clearing was 
statistically significant (p<0.001) 
Gonioscopy 
On gonioscopy at the preoperative examination, 1 O eyes (28.5%) shown 
iridocorneal angle dysgenesis, and 2 eyes (5.6%) had an angle closure configuration 
(less than 2 in Schaffer scale). 
Visual acuity 
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The data on visual acuity (figure 4) were available for 14 patients (50.0%). 
From 14 patients with available BCVA 8 patients (57.1 %) achieved 0.5 (20/40) or 
better, 3 (21.4%) 0.2 (20/1 OO), and 2 (14.3%) 0.1 (20/200) in their better eye (table 
2). One patient (7.2%) had severe visual impairment with finger counting at 1 meter. 
Refractive errors 
The data on refractive errors were available for 17 eyes (48.5%). The mean 
refractive error (spherical equivalent SE) in dioptre D at the final follow-up visits was 
+0.83 ± 5.4 (-7 +15.75 D). From these 17 eyes, 6 (35.3%) were myopie with a mean 
SE of -3.8 ± 1.6 (-2.5-7 D). Seven (41.2%) were hyperopic with a mean SE of +5.7 ± 
6.6 (0-16 D), from which 4 were suffering from aphakia. Four eyes (23.5%) were 
emmetropic with a SE of zero. Astigmatism was present in 13 eyes (76.5%) with a 
mean cylindrical correction of -2.2 ± 1.4 (-0.5-5 D)(table 2). 
Success rate 
Based on cumulative survival analysis, complete success rate using criterion 
A (> 6 mmHg but s 18 mmHg) was 52.3%. Using criterion B (> 6 mmHg but s 15 
mmHg), the success rate was 42.1 % (figure 5). Qualified success rates with criterion 
A was 70.6% and with criterion B 57.6%, respectively. From the 26 eyes with surgical 
success, 19 (76.1 %) had no prior surgery. For the primary congenital glaucoma, 6 
eyes out of 23 were classified as a failure due to the need for further surgery or lost 
of sight. For the developmental disorder glaucoma, 2 eyes out of 6 failed, and for the 
secondary glaucoma, 1 eye out of 6 was considered as a failure due to the need of 
vitrectomy following vitreous prolapse. From these 9 failures, 4 eyes (44.4%) 
underwent a mean of 2.8 (1-5) previous filtering surgeries. 
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Complications 
From the 35 eyes operated, 3 (8.6%) had severe complications that resulted 
in phthisis bulbi leading eventually to enucleation. Two of these eyes had several 
previous failed filtering surgeries with advanced glaucoma (mean CID= 0.8), but 
none had adjunctive treatments such as postoperative MMC injection. One case 
(neurofibromatosis) was suffering from endophthalmitis 1 week after the surgery (no 
previous filtering procedure) and despite vigorous intravitreal injections of antibiotics 
following pars plana vitrectomy the eye was lost. One eye (primary congenital 
glaucoma with congenital cataract) had uncontrolled IOP (> 26 mmHg) after the 
filtering surgery (phacoemulsification, vitrectomy, secondary intraocular lens 
implantation, trabeculectomy, were performed from 1 month to 6 years after birth) 
and laser cyclophotocoagulation was performed 4 times (from month 4 to month 15 
postoperative) before ending in phthisis bulbi. The last eye (primary congenital 
glaucoma initially treated by trabeculectomy at the age of 1 year) had elevated IOP 
(> 28 mmHg) and an implantation of a Baerveldt tube was performed 4 months after 
the combined surgery. Despite initial good IOP contrai, the tube was replaced 18 
months later due to tube migration but unfortunately severe choroidal detachment 
and aqueous misdirection occurred resulting in phthisis bulbi within 4 years. 
lntra-operative MMC (14 eyes) was given both in eyes with previous filtering surgery 
(n=6) to prevent recurrence of failure and in eyes with secondary glaucoma due to 
uveitis (n=3) or Sturge-Weber syndrome and neurofibromatosis (n=5). Postoperative 
application (n=7) was given when IOP was > 20 mmHg. The mean time between 
surgery and MMC application was 32.4 ± 17.8 days. Four eyes (57%) had an IOP < 
15 mmHg at last follow-up contrai without medication, 3 with one or two 
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antiglaucoma medications. Five eyes had primary congenital or juvenile glaucoma, 
and 2 had Sturge-Weber syndrome. 
Nine eyes (25.7%) had transient complications, from which 6 (17.2%) required 
further surgical revision (table 3). The 3 eyes that didn't required surgical revision 
had a good outcome at last visit with an IOP < 15 mmHg without medication. From 
the 6 eyes undergoing secondary surgery, the vitreous prolapse (in aphakia and 
previous vitrectomy) underwent successful anterior vitrectomy with secondary 
intraocular lens implantation with an IOP around 16 mmHg at last visit; the iris 
prolapse Quvenile glaucoma) was reduced and IOP was stable at 12 mmHg without 
medication; the cataract (in primary glaucoma) was removed uneventfully and the 
IOP was controlled below 18 mmHg with medications. The three cases of hypertony 
(2 primary glaucoma, 1 developmental glaucoma) were reoperated and a surgical 
revision was performed. The IOP was stable< 16 mmHg without medication. 
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Discussion 
The goal in the efficient management of pediatric glaucoma is to rapidly lower 
the IOP and to keep it low for a long term prospective. To achieve this challenging 
task, it is important to correctly understand the anatomopathological reasons leading 
to impairment in the drainage of the aqueous humer. 
The overall success after filtering surgery in pediatric glaucoma has been 
reported to be variable, depending on the surgical technique and the severity of the 
disease. 1 lt is generally accepted that the chances for good surgical success are the 
highest when only one surgery is required, and that successive procedures reduce 
the success rate. 6' 18 
ln this study we report the results on 35 eyes of 28 patients operated by 
combined deep sclerectomy and trabeculectomy in pediatric glaucoma. The IOP was 
lower than 18 mmHg for all but 5 eyes (84%) 3.5 years after surgery, and from the 26 
successful eyes 19 (76.1 %) which had no prier surgeries. This compares favorably 
with Mc Pherson and Berry who reported a 83% success rate after external 
trabeculectomy on 23 eyes. 18 Mullaney et al reported a 78% success rate using a 
combined trabeculoctomy-trabeculectomy technique in children's eyes without 
anterior segment anomalies. 14 Deep sclerectomy alone might prove to be 
challenging in achieving satisfactory IOP control in refractory congenital glaucoma. 
Lüke et al in a small series of 8 young patients mentioned a specific risk profile 
associated with deep sclerectomy in surgery for refractory congenital glaucoma. 19 
Conversion from deep sclerectomy to trabeculectomy was performed in four eyes 
and supplemented by a trabeculotomy in two eyes out of ten. Despite effective IOP 
reduction all eyes were ultimately classified as failures. Yet, in a study of a similar 
technique in 12 eyes, Tixier et al found no intraoperative or immediate postoperative 
complications. 20 The success rate at 10 months was 75%, IOP was elevated in 3 
eyes and one of them underwent re-operation. The difference between these two 
studies lies in the tact that Lüke was reporting on patients having a history of 
previous glaucoma surgery while in the series citied by Tixier only 3 of 12 eyes had 
two interventions before deep sclerectomy. Roche et al have evaluated the results of 
nonpenetrating external trabeculectomy for primary congenital glaucoma on 43 eyes 
of 27 consecutive patients with primary CG. 17 Of the 43 eyes, 13 required conversion 
to trabeculectomy because of insufficient filtration (9), apparent absence of 
Schlemm's canal (3) or accidentai perforation (1 ). ln the remaining 30 eyes, the 
success rate was 93% with a mean postoperative IOP of 10.8 mm Hg. The long-term 
follow-up is questionable in respect to the need for further goniopuncture. Cillino et al 
have compared the long-term effects of low-dosage mitomycin C (MMC) in both 
deep sclerectomy and trabeculectomy. 21 At the 48 months end-point either 
procedure controlled IOP efficaciously, a low-dosage MMC can be considered a mild 
enhancement of deep sclerectomy IOP-lowering effect. 
The reason for proposing modifications from the original deep sclerectomy is 
to avoid the complications reported by Lüke. The aim of performing deep 
sclerectomy is to reduce the size of the sub-conjunctival filtering bleb generally found 
after classic trabeculectomy. The idea is to bring the aqueous humor into the scierai 
space, and to enhance growing of intrascleral drainage pathway. 22 The reduction in 
the size of the sub-conjunctival filtering bleb can diminish the risks, complications 
and postoperative treatments related to larger blebs. ln a controlled case study in 
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adults, Nd:YAG laser goniopuncture was performed in 51 % of all patients after deep 
sclerectomy. 16 Performing laser goniopuncture in children might prove challenging. 
ln order to avoid the need of such laser goniopuncture, we have included the 
trabeculectomy in the surgical technique. This would prevent the thin trabeculo-
Descemet's membrane from limiting egress of aqueous humor after surgery. The 
new surgical technique, as a filtering procedure in pediatric glaucoma, takes 
advantage of the direct by-pass from the anterior chamber to a reservoir in the 
sciera. From that newly created space aqueous humor is drained through 3 different 
pathways: the subconjunctival space, the intrascleral route, and the subchoroidal 
space. ln trabeculectomy the main route goes though the subconjunctival space, 
resulting in a significant filtering bleb, and the two latter routes are not present due to 
the lack of a reservoir created during deep sclerectomy. The deep sclerectomy with 
external trabeculectomy combines the advantages of routing the aqueous humor 
thought these 3 pathways, thus reducing the height of the conjunctival bleb, and the 
direct removal of the main obstacle to aqueous egress at the level of the trabeculum. 
This modified technique is therefore no longer a non-penetrating procedure, such as 
for a standard non-penetrating deep sclerectomy, but it takes benefit from the deep 
sclerectomy approach in respect to the aqueous humor drainage. We have favored 
this procedure over goniotomy or trabeculectomy for the congenital, secondary and 
juvenile glaucoma patients in order to give them bath the best chance to efficiently 
lower the IOP on the long term while reducing the risk of sight threatening 
complications. A significant number (34%) of eyes presented with a cornea oedema 
which prevented a clear view of the angle for a safe goniotomy. For this reason this 
technique was not selected in this case series. Deep sclerectomy in adults has 
proven to be a safe an efficient procedure providing stable and reasonable contrai of 
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IOP at long-term follow-up in a 96 month study. 16 Based on these results, we have 
included the deep sclerectomy with external trabeculectomy at first line of treatment 
in our algorithm for handling congenital and juvenile glaucomas. 
Measurements of the IOP in children often requires general anesthesia and 
the effects of anesthetics may increase or decrease IOP with changing outcomes 
over time, depending on the level of anesthesia. 5 Halothane was reported to 
significantly lower IOP. 4 Controversy still exists as to the extent to which IOP is 
reduced after general anesthesia with gas anesthetics. ln a study comparing IOP 
measurements of infants under bath awake and sedated conditions, Quigley found 
that the IOP in the awake state was similar to that after ketamine sedation, whereas 
gas anesthetics similar to sevoflurane lowered IOP. 7 Blumberg et al, in a paper 
reporting the effects of sevoflurane, a gas anesthetic and ketamine, found that the 
IOP was significantly lowered by about 7 mmHg during sevoflurane anesthesia 
compared to ketamine alone. 5 We have segregated the IOP measurements in two 
groups, one including data obtained under topical anesthesia, and the other one for 
data obtained under general gas anesthesia (Figures 1 and 2). We have observed 
that IOP measurements under gas anesthesia were lower than that under an awake 
state with topical anesthesia, thus confirming the remarks from previous studies 
about the lowering effects of gas anesthetics. 
The limitations of this study are the retrospective non-comparative design, the 
small number of developmental and secondary glaucoma, the variability in the IOP 
measuring technique due to the general anesthesia, and the lack of visual acuity 
data in hait of the patients. The patient selection was based on the surgeon's 
21 
experience and this could have induced a bias in the indication for such surgery. 
Approximately 1 /3 of eyes with corneal edema or myopia were considered a 
relatively mild disease when compared to some studies in the literature. 3· 12· 13 The 
strength of our study lies in the tact that the same technique was used by the same 
surgeon for all surgeries, and in the number of eyes operated, which compares 
favourably to other studies. 3 
ln conclusion the combined deep sclerectomy and trabeculectomy is a 
surgical technique recently developed to contrai IOP in congenital, secondary and 
juvenile glaucomas. The intermediate results are satisfactory and promising in 
lowering the IOP over time. The best results are found when this surgery is the first 
filtering procedure, which reduces the complications related to the trabeculectomy 
only. Unfortunately when other glaucoma surgeries are performed before this 
technique the outcomes are less favourable. The results indicate that the number of 
sight threatening complications is related to the severity of the glaucoma and the 
number of previous failed surgeries. Great care should be given in indicating the 
correct surgical technique in order to avoid further surgery, thus reducing the risk of 
complications and surgical failure. 
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Table 1. Demographics 
Demographics No(%) 
Number of eyes 35 
Male/ Female (n=28) 15 (53.6) / 13 (46.4) 
Age at surgery (mean years ± SD) 3.6 ± 4.5 
Range 3 days-13 years 
Caucasians / African 27/1 
Diagnosis (n=patients) No of eyes (%) 
Primary congenital glaucoma (n=17) 23 (65.8) 
Developmental disorders glaucoma (n=6) 6 (17.1) 
Secondary glaucoma (n=5) 6 (17.1) 
Total previous surgeries (n=8) 10 (28.6%) 
Filtering surgeries (n=5) 6 (17.1%) 
Follow-up (mean years ± SD) 3.5 ± 2.9 
Range 3 months-9.1 years 
Preoperative IOP (mean mmHg ± SD) 31.9 ± 11.5 
Ranqe 16-53 
Preoperative medications per patient (mean ± SD) 1.1±1.7 
Range 0-5 
Horizontal corneal diameters (mean mm ± SD) 13.1±1.4 
Rançie 10-17 
Corneal oedema 12 (34.3) 
Cornea Haab striation 11 (31.4) 
Angle dysgenesis 10 (28.5%) 
Snellen preoperative BCVA (mean ± SD) (n=14) 0.43 ± 0.32 
Range FC-0.9 
Ultrasound axial length (mean mm ± SD) 23.3 ± 3.7 
Rançie 19-32 
Optic dise CID 0.62 ± 0.25 
Ranqe 0.25-1.0 
Legends: BCVA: best corrected visual acuity; C/D: cup/disc ratio; FC: finger counting 
at 1 meter; IOP: intraocular pressure; SD: standard deviation 
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Table 2. Postoperative results 
Results No(%) 
Postoperative IOP (mean mmHg ± SD) 13.3 ± 5.6 
Ranqe 2-31 
Postoperative medications per patient (mean ± SD) 0.4 ± 0.7 
Ranqe 0-3 
Horizontal corneal diameters (mean mm ± SD)t 13.2 ± 1.3 
Ranqe 12-16 
Corneal oedema 1 (2.8) 
Cornea Haab's striae 11 (31.4) 
Snellen postoperative BCVA (mean ± SD) (n=14) 0.66 ± 0.36 
Range FC-1.0 
Spherical equivalent refractive error (mean D ± SD) (n=17) +0.83 ± 5.4 
Ranqe -7 +15.75 
Ultrasound axial length (mean mm± SD) 23.8 ± 2.7 
Ranqe 20-32 
Number of superficial flap suture (mean ± SD) 4.4 ± 2.4 
Range 0-8 
Number of perioperative MMC application 14 (40) 
Duration of perioperative MMC application (mean sec ± SD) 60 ±34 
Ranqe 30-120 
Legends: BCVA: best corrected visual acuity; D: dioptre; FC: finger counting at 1 
meter; IOP: intraocular pressure; MMC: Mitomycin C; SD: standard deviation t: One 
year after surgery. 
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Table 3. Complications 
Results No(%) 
Major complications 3 (8.6) 
Phthisis bulbi 2 (5.7) 
Endophthalmitis 1 (2.9) 
Minor complications 9 (25.7) 
Corneal ulceration 1 (2.9) 
Hypotony* 1 (2.9) 
Choroidal detachment 1 (2.9) 
Vitreous prolapse in the anterior chambert 1 (2.9) 
Iris incarcerationt 1 (2.9) 
Hypertonyt 3 (8.6) 
Cataractt 1 (2.9) 
Number of postoperative MMC application 7 (20) 
Legends: MMC: Mitomycin C. *Hypotony was defined as IOP(intraocular pressure) s 
6 mmHg. t: Required further surgery. 
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Table 4. Mean IOP over time 
Follow-up months Mean IOP mm Hg 
(number of patients) ±SD 
12 (35) 13.8 ± 5.4 
24 (32) 15.2 ± 2.2 
36 (25) 14.8 ± 2.2 
48 (21) 13.7 ± 3.4 
60 (18) 15.6 ± 4.8 
72 (12) 13.6 ± 4.7 
84 (11) 14.7±9.6 
96 (11) 14.6 ± 4.9 
108(10) 13.3 ± 5.6 
Legends: IOP: intraocular pressure; SD: standard deviation 
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Legends for figures 
Figure 1. Scattered graph of the mean pre-and postoperative intraocular pressure 
(IOP) (n=32) 
Figure 2. Box-plots of the mean intraocular pressure (IOP) for topical (top) and 
general anesthesia (bottom) tonometry measurements (n=35) 
Figure 3. Mean number of antiglaucoma medication per patient before and after 
surgery (n=35) 
Figure 4. Scattered graph of the mean pre-and postoperative Snellen best corrected 
visual acuity (BCVA) (n=14) 
Figure 5. Kaplan-Meier survival curve showing the failure rate. Top: Success criterion 
A (s;1 s mmHg). Bottom: Success criterion B ((s;15 mmHg). 
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Figure 2. 
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Figure 3. 
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Figure 4. 
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